Literature DB >> 17895555

Prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in a Japanese population: a middle-term follow-up study.

Naoya Matsumoto1, Yuichi Sato, Yasuyuki Suzuki, Taeko Kunimasa, Shunichi Yoda, Jun Iida, Yoshimochi Nakano, Akihiro Yoshimura, Takaaki Miki, Masahiko Kato, Shinro Matsuo, Satoshi Saito, Atsushi Hirayama.   

Abstract

BACKGROUND: The prognostic value of rest 201Tl/stress (99m)Tc-tetrofosmin myocardial perfusion single-photon emission computed tomography (SPECT) for the prediction of future hard cardiac events, including acute myocardial infarction (AMI), unstable angina (UAP) and cardiac death, and the implications for risk stratification has not yet been defined in a Japanese population. METHODS AND
RESULTS: The 1,988 patients who underwent rest 201Tl/stress (99m)Tc-tetrofosmin SPECT were identified and followed up for the occurrence of AMI, UAP and cardiac death. The mean follow-up interval was 26.9+/-15.8 months. The 142 patients were revascularized within 60 days after SPECT and they were censored from the prognostic analysis. Summed stress score (SSS), summed rest score and summed difference score (SDS) were calculated using a 5-point scoring (Normal: 0, No uptake: 4) and a 20-segment model; 22 cases of myocardial infarction, 31 of UAP and 22 cardiac deaths occurred (1.2%, 1.7% and 1.2%, respectively). Multivariate Cox regression analysis showed that hypertension (Wald 6.37, p<0.05) and SDS (Wald 8.77, p<0.01) were independent predictors of AMI and UAP. Advanced age (Wald 16.0, p<0.001), SSS (Wald 10.9, p<0.01) and SDS (Wald 4.58, p<0.05) were independent predictors of cardiac death.
CONCLUSION: Myocardial perfusion SPECT yields prognostic information toward the identification of acute coronary syndrome and cardiac death.

Entities:  

Mesh:

Year:  2007        PMID: 17895555     DOI: 10.1253/circj.71.1580

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

Review 1.  SPECT and PET in ischemic heart failure.

Authors:  George Angelidis; Gregory Giamouzis; Georgios Karagiannis; Javed Butler; Ioannis Tsougos; Varvara Valotassiou; George Giannakoulas; Nikolaos Dimakopoulos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis; Panagiotis Georgoulias
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

2.  Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease.

Authors:  Kenichi Nakajima; Satoko Nakamura; Hiroki Hase; Yasuchika Takeishi; Shigeyuki Nishimura; Yuhei Kawano; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

3.  Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.

Authors:  Amjad M Ahmed; Waqas T Qureshi; Wesley T O'Neal; Fatima Khalid; Mouaz H Al-Mallah
Journal:  J Nucl Cardiol       Date:  2017-01-03       Impact factor: 5.952

4.  Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Robert C Hendel; Gary V Heller; Salvador Borges-Neto; Manuel Cerqueira; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2008-09-12       Impact factor: 5.952

5.  Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study.

Authors:  Shu Kasama; Takuji Toyama; Makito Sato; Hirokazu Sano; Tetsuya Ueda; Toyoshi Sasaki; Takehiro Nakahara; Tetsuya Higuchi; Yoshito Tsushima; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-25       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.